Cryptosporidiosis in humans: review of recent epidemiologic studies.

Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Cryptosporidiosis in humans: review of recent epidemiologic studies.

Eur J Epidemiol. 1985 Jun;1(2):77-83. Unique Identifier : AIDSLINE MED/87054561
Navin TR

Abstract: Since 1976, when Cryptosporidium was first recognized as a human pathogen, understanding of the epidemiology of this protozoan parasite has increased substantially. This review discusses 14 recently published studies of the occurrence of cryptosporidiosis in developed and developing countries and compares their findings with those of previous epidemiologic reports. These studies show that cryptosporidiosis is an important public health problem worldwide. Although cryptosporidiosis was first recognized as a problem in immunosuppressed patients, persons with normal immunologic function are also affected. This appears to be especially true for children in developing countries; of 1035 children with diarrhea reported in several surveys, 79 (7.6%) had Cryptosporidium. Findings from studies that included both asymptomatic as well as symptomatic persons have demonstrated that Cryptosporidium infections are rare in persons without symptoms, suggesting that Cryptosporidium should not be thought of as an opportunistic parasite. Early studies documented the potential for animal-to-human transmission of Cryptosporidium, but it is now clear that many, perhaps most, Cryptosporidium infections in humans are not acquired directly from infected animals. Although alternate modes of transmission are just beginning to be explored, evidence indicates that person-to-person spread is important.

Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS Adult Age Factors Animal Child Cryptosporidiosis/COMPLICATIONS/*EPIDEMIOLOGY/TRANSMISSION Diarrhea Human JOURNAL ARTICLE REVIEW

870330
M8730266

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .